𝗧𝗵𝗲 𝗳𝗶𝘃𝗲-𝘆𝗲𝗮𝗿 𝘀𝘂𝗿𝘃𝗶𝘃𝗮𝗹 𝗿𝗮𝘁𝗲 𝗳𝗼𝗿 𝗮𝗹𝗹 𝗰𝗮𝗻𝗰𝗲𝗿𝘀 𝗰𝗼𝗺𝗯𝗶𝗻𝗲𝗱 𝗶𝘀 𝗮𝗿𝗼𝘂𝗻𝗱 𝟳𝟬%.

𝗙𝗼𝗿 𝗴𝗹𝗶𝗼𝗯𝗹𝗮𝘀𝘁𝗼𝗺𝗮, 𝗶𝘁’𝘀 𝗼𝗻𝗹𝘆 𝟳%. A glioblastoma diagnosis doesn’t have to come with such devastating odds. That’s why we’re working to make genomic testing available to every glioblastoma patient — helping personalize treatment and identify targeted therapies based on the unique biology of every tumor. Our mission is simple: to transform glioblastoma from terminal to treatable and make survival the expectation, not the exception. Donate today at the link in bio to help ensure more patients have a story beyond five years. 💜 #GlioblastomaFoundation #GenomicTesting #Glioblastoma #BrainCancer #TransformingGlioblastomaTherapy